Matches in SemOpenAlex for { <https://semopenalex.org/work/W1776223521> ?p ?o ?g. }
- W1776223521 endingPage "1998" @default.
- W1776223521 startingPage "1989" @default.
- W1776223521 abstract "Vatreptacog alfa, a recombinant human factor VIIa (rFVIIa) analog developed to improve the treatment of bleeds in hemophilia patients with inhibitors, differs from native FVIIa by three amino acid substitutions. In a randomized, double-blind, crossover, confirmatory phase III trial (adept(™) 2), 8/72 (11%) hemophilia A or B patients with inhibitors treated for acute bleeds developed anti-drug antibodies (ADAs) to vatreptacog alfa.To characterize the formation of anti-vatreptacog alfa ADAs in hemophilia patients with inhibitors.This was a post hoc analysis of adept(™) 2. Immunoglobulin isotype determination, specificity analysis of rFVIIa cross-reactive antibodies, epitope mapping of rFVIIa single mutant analogs and pharmacokinetic (PK) profiling were performed to characterize the ADAs.Immunoglobulin isotyping indicated that the ADAs were of the immunoglobulin G subtype. In epitope mapping, none of the rFVIIa single mutant analogs (V158D, E296V or M298Q) contained the complete antibody epitope, confirming that the antibodies were specific for vatreptacog alfa. In two patients, for whom PK profiling was performed both before and after the development of ADAs, vatreptacog alfa showed a prolonged elimination phase following ADA development. During the follow-up evaluation, the rFVIIa cross-reactivity disappeared after the last vatreptacog alfa exposure, despite continued exposure to rFVIIa as part of standard care.Results from the vatreptacog alfa phase III trial demonstrate that the specific changes made, albeit relatively small, to the FVIIa molecule alter its clinical immunogenicity." @default.
- W1776223521 created "2016-06-24" @default.
- W1776223521 creator A5004338432 @default.
- W1776223521 creator A5005733403 @default.
- W1776223521 creator A5010706893 @default.
- W1776223521 creator A5016306582 @default.
- W1776223521 creator A5017307924 @default.
- W1776223521 creator A5017819710 @default.
- W1776223521 creator A5018280451 @default.
- W1776223521 creator A5021194298 @default.
- W1776223521 creator A5028307194 @default.
- W1776223521 creator A5031524050 @default.
- W1776223521 creator A5032616805 @default.
- W1776223521 creator A5034952955 @default.
- W1776223521 creator A5035546452 @default.
- W1776223521 creator A5038277854 @default.
- W1776223521 creator A5038801192 @default.
- W1776223521 creator A5040642891 @default.
- W1776223521 creator A5042973148 @default.
- W1776223521 creator A5043916164 @default.
- W1776223521 creator A5047434427 @default.
- W1776223521 creator A5048740921 @default.
- W1776223521 creator A5051269559 @default.
- W1776223521 creator A5062598474 @default.
- W1776223521 creator A5063491781 @default.
- W1776223521 creator A5065330689 @default.
- W1776223521 creator A5066790024 @default.
- W1776223521 creator A5068420742 @default.
- W1776223521 creator A5069953991 @default.
- W1776223521 creator A5070640404 @default.
- W1776223521 creator A5073241613 @default.
- W1776223521 creator A5073322625 @default.
- W1776223521 creator A5073535547 @default.
- W1776223521 creator A5074654320 @default.
- W1776223521 creator A5075634933 @default.
- W1776223521 creator A5076921639 @default.
- W1776223521 creator A5081111482 @default.
- W1776223521 creator A5081907928 @default.
- W1776223521 creator A5082757602 @default.
- W1776223521 creator A5083828440 @default.
- W1776223521 creator A5085306795 @default.
- W1776223521 creator A5087552786 @default.
- W1776223521 creator A5088720234 @default.
- W1776223521 creator A5089009870 @default.
- W1776223521 date "2015-10-13" @default.
- W1776223521 modified "2023-10-15" @default.
- W1776223521 title "Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity" @default.
- W1776223521 cites W1525674540 @default.
- W1776223521 cites W1594032348 @default.
- W1776223521 cites W1603310021 @default.
- W1776223521 cites W1716063121 @default.
- W1776223521 cites W1964530118 @default.
- W1776223521 cites W1989379557 @default.
- W1776223521 cites W2008716770 @default.
- W1776223521 cites W2012027479 @default.
- W1776223521 cites W2016711607 @default.
- W1776223521 cites W2024207765 @default.
- W1776223521 cites W2039117140 @default.
- W1776223521 cites W2065711632 @default.
- W1776223521 cites W2067656210 @default.
- W1776223521 cites W2078111654 @default.
- W1776223521 cites W2083867821 @default.
- W1776223521 cites W2090723639 @default.
- W1776223521 cites W2091721067 @default.
- W1776223521 cites W2095028303 @default.
- W1776223521 cites W2095880443 @default.
- W1776223521 cites W2098951552 @default.
- W1776223521 cites W2117437723 @default.
- W1776223521 cites W2123764760 @default.
- W1776223521 cites W2126721202 @default.
- W1776223521 cites W2129609495 @default.
- W1776223521 cites W2130429639 @default.
- W1776223521 cites W2331969526 @default.
- W1776223521 cites W4321429161 @default.
- W1776223521 doi "https://doi.org/10.1111/jth.13141" @default.
- W1776223521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26362483" @default.
- W1776223521 hasPublicationYear "2015" @default.
- W1776223521 type Work @default.
- W1776223521 sameAs 1776223521 @default.
- W1776223521 citedByCount "47" @default.
- W1776223521 countsByYear W17762235212016 @default.
- W1776223521 countsByYear W17762235212017 @default.
- W1776223521 countsByYear W17762235212018 @default.
- W1776223521 countsByYear W17762235212019 @default.
- W1776223521 countsByYear W17762235212020 @default.
- W1776223521 countsByYear W17762235212021 @default.
- W1776223521 countsByYear W17762235212022 @default.
- W1776223521 countsByYear W17762235212023 @default.
- W1776223521 crossrefType "journal-article" @default.
- W1776223521 hasAuthorship W1776223521A5004338432 @default.
- W1776223521 hasAuthorship W1776223521A5005733403 @default.
- W1776223521 hasAuthorship W1776223521A5010706893 @default.
- W1776223521 hasAuthorship W1776223521A5016306582 @default.
- W1776223521 hasAuthorship W1776223521A5017307924 @default.
- W1776223521 hasAuthorship W1776223521A5017819710 @default.
- W1776223521 hasAuthorship W1776223521A5018280451 @default.
- W1776223521 hasAuthorship W1776223521A5021194298 @default.
- W1776223521 hasAuthorship W1776223521A5028307194 @default.